To decrease the risk of infections in ALL patients, it is required to reduce the duration of poor innate host defenses against infection, improve acquired immunity through vaccines or Igs, practice good hygiene, and use antibiotic prophylaxis for specific at-risk patients. This evidence concerns the gene CUBN and acute lymphoblastic leukemia.